Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
102D-6 in the Treatment of Uncomplicated Influenza
NCT07893847Phase 3Not yet recruiting
- Sponsor
- Capital Medical University
- Start
- Oct 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 3 trial of baloxavir marboxil in influenza, sponsored by Capital Medical University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07893847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07893847.